Patent ID: 6316458
Filing Date: 2001-11-13
Classification: A61K,A61P

Abstract:
A method of treating a patient with Type II diabetes, impaired glucose tolerance, obesity, dyslipidemia, hyperuricemia, impaired fibrinolysis, or polycystic ovary disease, comprising administering to a patient that suffers from Type II diabetes, impaired glucose tolerance, obesity, dyslipidemia, hyperuricemia, impaired fibrinolysis, or polycystic ovary disease an effective amount of at least one xanthine-based compound, or a pharmaceutically acceptable salt thereof, having the following structure: ##STR3##wherein:R.sub.1 is an R enantiomer of an .omega.-1 secondary alcohol-substituted alkyl (C.sub.5-8), wherein said alcohol moiety is optionally esterified;R.sub.2 is alkyl (C.sub.1-12), optionally containing one or two nonadjacent oxygen atoms in place of a carbon atom; andR3 is CH3 or H.